81.505
-1.45 (-1.74%)
-1.45 (-1.74%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -1.45 | -1.74% | 81.505 | 15:50:32 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 81.25 | 83.44 | 83.44 | 82.95 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 59,543 | 5,957,211 | $ 82.00 | $ 488,462,952 | 7,981,098 | 65.25 - 92.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:50:32 | 100 | $ 81.505 | USD |
Merck Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 206.15B | 2.53B | 2.53B | $ 46.84B | $ 10.42B | 3.81 | 20.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 10.97M | $ 2.26 | 2.77% | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 81.86 | 85.81 | 81.25 | 82.77 | 7,451,363 | -0.355 | -0.43% |
| 1 Month | 87.69 | 87.80 | 81.25 | 84.10 | 8,600,923 | -6.19 | -7.05% |
| 3 Months | 77.94 | 87.80 | 76.04 | 82.40 | 7,896,719 | 3.57 | 4.57% |
| 6 Months | 74.66 | 87.80 | 72.92 | 80.23 | 9,403,352 | 6.85 | 9.17% |
| 1 Year | 84.18 | 92.64 | 65.25 | 81.37 | 10,043,299 | -2.68 | -3.18% |
| 3 Years | 64.21 | 92.64 | 52.83 | 73.27 | 10,278,625 | 17.30 | 26.94% |
| 5 Years | 49.35 | 92.64 | 47.97 | 68.06 | 9,684,366 | 32.16 | 65.16% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. |
